NCT06278597

Brief Summary

The aim of the study is to evaluate an objective, non-invasive optical device able to quantify, without eye contact, the width of the irido-corneal angle and to better identify cases of narrow angle or angle closure that may be prevented with relatively simple treatments.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 5, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2024

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

February 15, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 26, 2024

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

March 7, 2025

Status Verified

February 1, 2025

Enrollment Period

5 months

First QC Date

February 15, 2024

Last Update Submit

March 5, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Agreement between the automatic Narrow Anterior Chamber Angle Estimator grading of peripheral anterior chamber width with clinical grading as performed by Van Herick (VH) test at slit lamp

    The angle is graded by the NACA estimator as the ratio between the peripheral anterior chamber depth and limbal-corneal thickness, as observed in the slit lamp by the microscope section. A high-resolution camera will synchronously acquire the images to generate the irido-corneal angle grade that will be classified in four grades following the VH classification. The standard VH grading scale will be: * 1 = space between iris and corneal endothelium of \<¼ corneal thickness (angle closure likely), * 2 = space between iris and corneal endothelium of ¼ corneal thickness (angle closure possible), * 3 = space between iris and corneal endothelium of ½ corneal thickness (angle closure unlikely), * 4 = space between iris and corneal endothelium ≥ 1 (corneal thickness angle closure very unlikely).

    12 months

  • Agreement between the automatic Narrow Anterior Chamber Angle Estimator grading of peripheral anterior chamber width with clinical grading as performed by gonioscopy.

    The angle will be graded for each quadrant at gonioscopy using the modified Shaffer grading system, by which each grade corresponds to the visibility of the different angle structures.

    12 months

Secondary Outcomes (2)

  • Reproducibility (intra-session) and repeatability (inter-session) of the peripheral anterior chamber width (PACW) evaluation by the Narrow Anterior Chamber Angle Estimator

    12 months

  • Sensitivity and specificity of NACA Estimator grading of PACW in detecting primary angle closure suspects as classified by clinical gonioscopy.

    12 months

Interventions

NACA EstimatorDIAGNOSTIC_TEST

Grading of peripheral anterior chamber width with the Narrow Anterior Chamber Angle (NACA) Estimator

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Willingness to participate and ability to understand and sign an informed consent.
  • years of age or older.
  • Healthy subjects, patients with PACS or angle closure as defined by the EGS Guidelines.
  • The right eye will be included in the study for all patients, unless a clinical contraindication to the examination is present.

You may not qualify if:

  • Inability to understand and sign an informed consent.
  • Any prior ocular surgery or laser treatment with the potential to alter the natural anatomy of the anterior segment of the eye.
  • Corneal or conjunctival abnormalities that preclude an adequate view of the anterior chamber.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Fondazione GB Bietti

Roma, Italy, 00184, Italy

Location

MeSH Terms

Conditions

Glaucoma

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 15, 2024

First Posted

February 26, 2024

Study Start

September 5, 2023

Primary Completion

January 20, 2024

Study Completion

December 31, 2024

Last Updated

March 7, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations